secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001193125-24-258668
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma approves $360k CEO bonus, $162k Exec Director bonus for FY2024
--------------------------------------------------------------------------------

- Compensation Committee approved discretionary bonus of $360,360 for CEO Jerel Banks for FY ending June 30, 2024.
- Executive Director Megan Boston received a bonus of $161,580 (converted from AUD at ~0.67 USD/AUD).
- Bonuses were approved on November 7, 2024, and reflect performance during fiscal year 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524258668/0001193125-24-258668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524258668/d873209d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-258668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer